Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Novartis AG.
Novartis AG business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Novartis AG are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Novartis AG , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Novartis AG including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Novartis AG and all latest updates of the company are provided.
The 2025 version of Novartis AG report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Novartis AG- Key Facts
2.2 Novartis AG- Geographic Locations
2.3 Novartis AG- Subsidiaries and Affiliates
2.4 Novartis AG- Business Divisions
2.5 Novartis AG- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Novartis AG Strategic Analysis Review
3.1 Novartis AG- Key Strategies
3.2 Novartis AG- Company Outlook Statement
3.3 Novartis AG- SWOT Analysis
3.3.1 Novartis AG- Key Strengths
3.3.2 Novartis AG- Key Weaknesses
3.3.3 Novartis AG- Potential Opportunities
3.3.4 Novartis AG- Potential Threats
3.4 Novartis AG- Key Competitors
4. Business Description of the Company
4.1 Novartis AG- Business Overview
4.2 Novartis AG- Operations by Segment
5 Products and Services Details
5.1 Novartis AG- Key Products
5.2 Novartis AG- Key Service Areas
5.3 Novartis AG- Key Brands
6 Company Developments
6.1 Novartis AG- Company History
6.2 Novartis AG- Latest Developments
7 Financial Analysis
7.1 Novartis AG- Income Statements
7.2 Novartis AG- Balance Sheet
7.3 Novartis AG- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Novartis AG- Direct Competitors
8.2 Novartis AG- Competitor Financial Ratios comparison
8.3 Novartis AG- Competitor Stock Charts Comparison
8.4 Novartis AG- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!